Ajanta Pharma bags India’s "Best Managed Companies" award
For the last ten financial years, the company has posted healthy performance with its revenue from operations growing at 15% CAGR and net profit at 23% CAGR
For the last ten financial years, the company has posted healthy performance with its revenue from operations growing at 15% CAGR and net profit at 23% CAGR
UNICEF award is worth US $98.755 million for supply of around 99.70 million doses during calendar years 2023-2027
The booster vaccination trial is still ongoing and further data will provide more information around safety and efficacy.
Further, ICAR-IVRI have jointly developed a Lumpy Skin Disease vaccine and as soon as the technology is made available, Hester will acquire the same and manufacture and commercialize the Lumpy Skin disease Vaccine
Kokilaben Hospital is also the first hospital in Navi Mumbai to receive the SMART ICU certification
Azelis’ customers now have access to products including the well-established Polyglykol portfolio, as well as a brand-new range of Motusflex and VitiPure excipients.
Expanding precision medicine, ARTIS icono is designed to enable a wide procedure mix in a single interventional suite
Japan’s Ministry of Health, Labour and Welfare (MHLW) has recently approved AstraZeneca's long-acting antibody combination “Evusheld” for the prevention ) and treatment of COVID-19.
The OAI classification implies that the USFDA expects further corrective actions and may withhold approval of any pending product applications or supplements filed from this facility till the outstanding observations are resolved
Subscribe To Our Newsletter & Stay Updated